Cheryl Smith, FNP | |
5429 Wrightsville Ave, Wilmington, NC 28403-6513 | |
(910) 792-1001 | |
(910) 792-1004 |
Full Name | Cheryl Smith |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 5429 Wrightsville Ave, Wilmington, North Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316083520 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 201779 (North Carolina) | Secondary |
363LF0000X | Nurse Practitioner - Family | 201779 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cheryl Smith, FNP 5429 Wrightsville Ave, Wilmington, NC 28403-6513 Ph: (910) 792-1001 | Cheryl Smith, FNP 5429 Wrightsville Ave, Wilmington, NC 28403-6513 Ph: (910) 792-1001 |
News Archive
A University of Michigan surgeon has found a way to successfully perform laparoscopic gallbladder removal in Nicaragua, despite limited clinical resources and poor operating room conditions.
New research using animal models is enabling a deeper understanding of the neurobiology of compulsive drug addiction in humans - knowledge that may lead to more effective treatment options to weaken the powerful cravings that cause people to relapse.
Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.
James Bray, professor and chair of the UTSA Department of Psychology, is working on a research project with agencies in Houston to train first responders in how to detect prescription opioid overdoses and provide life-saving outreach services.
Even as vaccines against SARS-CoV-2 are being developed and administered at an unprecedented pace, treating this infection remains a challenge. To address this, researchers from China have used nanobodies (Nb) as a possible therapeutic approach. They reported Nb phage display libraries derived from four camels immunized with the SARS-CoV-2 spike RBD.
› Verified 3 days ago